BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Infinity Pharmaceuticals, Inc. (INFIQ)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Infinity Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
2:01 pm
Sale		 2021-12-31 13G Infinity Pharmaceuticals, Inc.
INFIQ		 BIOTECHNOLOGY VALUE FUND L P 6,353,645
7.100%		 -2,030,000decrease
(-24.21%)		 Filing
2021-02-19
5:10 pm
Unchanged		 2021-02-17 13G Infinity Pharmaceuticals, Inc.
INFIQ		 BIOTECHNOLOGY VALUE FUND L P 8,383,645
9.960%		 0
(Unchanged)		 Filing
2021-02-16
4:30 pm
Sale		 2021-02-11 13D Infinity Pharmaceuticals, Inc.
INFIQ		 BIOTECHNOLOGY VALUE FUND L P 8,383,645
13.100%		 -2,343,323decrease
(-21.85%)		 Filing
2021-01-26
5:26 pm
Sale		 2021-01-22 13D Infinity Pharmaceuticals, Inc.
INFIQ		 BIOTECHNOLOGY VALUE FUND L P 10,726,968
16.700%		 -6,700,000decrease
(-38.45%)		 Filing
2020-11-12
5:13 pm
Unchanged		 2020-11-09 13D Infinity Pharmaceuticals, Inc.
INFIQ		 BIOTECHNOLOGY VALUE FUND L P 17,426,968
27.100%		 0
(Unchanged)		 Filing